Agilent Technologies PE Ratio 2010-2025 | A
Current and historical p/e ratio for Agilent Technologies (A) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Agilent Technologies PE ratio as of May 05, 2025 is 20.46.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Agilent Technologies PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-05-05 | 108.37 | 24.91 | |
| 2025-01-31 | 151.20 | $4.35 | 34.76 |
| 2024-10-31 | 129.79 | $4.42 | 29.37 |
| 2024-07-31 | 140.62 | $4.82 | 29.17 |
| 2024-04-30 | 136.03 | $4.23 | 32.16 |
| 2024-01-31 | 128.93 | $4.20 | 30.70 |
| 2023-10-31 | 102.27 | $4.21 | 24.29 |
| 2023-07-31 | 120.23 | $3.82 | 31.47 |
| 2023-04-30 | 133.46 | $4.54 | 29.40 |
| 2023-01-31 | 149.63 | $4.43 | 33.78 |
| 2022-10-31 | 135.91 | $4.17 | 32.59 |
| 2022-07-31 | 131.51 | $4.39 | 29.96 |
| 2022-04-30 | 116.76 | $4.15 | 28.13 |
| 2022-01-31 | 136.18 | $3.94 | 34.56 |
| 2021-10-31 | 153.73 | $3.94 | 39.02 |
| 2021-07-31 | 149.39 | $3.20 | 46.68 |
| 2021-04-30 | 130.12 | $2.98 | 43.66 |
| 2021-01-31 | 116.83 | $2.60 | 44.93 |
| 2020-10-31 | 99.09 | $2.30 | 43.08 |
| 2020-07-31 | 93.33 | $2.21 | 42.23 |
| 2020-04-30 | 74.12 | $2.17 | 34.16 |
| 2020-01-31 | 79.62 | $2.42 | 32.90 |
| 2019-10-31 | 72.90 | $3.36 | 21.70 |
| 2019-07-31 | 66.65 | $3.35 | 19.90 |
| 2019-04-30 | 75.22 | $3.48 | 21.61 |
| 2019-01-31 | 72.72 | $3.54 | 20.54 |
| 2018-10-31 | 61.80 | $0.98 | 63.06 |
| 2018-07-31 | 62.86 | $0.91 | 69.08 |
| 2018-04-30 | 62.42 | $0.72 | 86.70 |
| 2018-01-31 | 69.56 | $0.59 | 117.91 |
| 2017-10-31 | 64.31 | $2.10 | 30.62 |
| 2017-07-31 | 56.40 | $1.94 | 29.07 |
| 2017-04-30 | 51.81 | $1.78 | 29.11 |
| 2017-01-31 | 45.98 | $1.56 | 29.47 |
| 2016-10-31 | 40.79 | $1.41 | 28.93 |
| 2016-07-31 | 44.93 | $1.45 | 30.98 |
| 2016-04-30 | 38.11 | $1.38 | 27.62 |
| 2016-01-31 | 34.97 | $1.35 | 25.90 |
| 2015-10-31 | 34.97 | $1.19 | 29.39 |
| 2015-07-31 | 37.82 | $0.82 | 46.12 |
| 2015-04-30 | 38.11 | $0.94 | 40.54 |
| 2015-01-31 | 34.71 | $1.10 | 31.55 |
| 2014-10-31 | 36.25 | $1.47 | 24.66 |
| 2014-07-31 | 36.69 | $2.05 | 17.90 |
| 2014-04-30 | 35.27 | $2.11 | 16.72 |
| 2014-01-31 | 37.86 | $2.18 | 17.37 |
| 2013-10-31 | 32.98 | $2.11 | 15.63 |
| 2013-07-31 | 28.99 | $2.68 | 10.82 |
| 2013-04-30 | 26.78 | $2.88 | 9.30 |
| 2013-01-31 | 28.86 | $3.12 | 9.25 |
| 2012-10-31 | 23.14 | $3.26 | 7.10 |
| 2012-07-31 | 24.55 | $2.88 | 8.53 |
| 2012-04-30 | 26.98 | $3.11 | 8.67 |
| 2012-01-31 | 27.10 | $2.95 | 9.19 |
| 2011-10-31 | 23.65 | $2.84 | 8.33 |
| 2011-07-31 | 26.90 | $2.68 | 10.04 |
| 2011-04-30 | 31.85 | $2.34 | 13.61 |
| 2011-01-31 | 26.69 | $2.09 | 12.77 |
| 2010-10-31 | 22.21 | $1.77 | 12.55 |
| 2010-07-31 | 17.82 | $1.18 | 15.10 |
| 2010-04-30 | 23.14 | $0.54 | 42.85 |
| 2010-01-31 | 17.89 | $-0.06 | 0.00 |
| 2009-10-31 | 15.79 | $-0.10 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $30.971B | $6.510B |
| Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.085B | 27.79 |
| Boston Scientific (BSX) | United States | $155.238B | 38.86 |
| Stryker (SYK) | United States | $144.362B | 30.18 |
| EssilorLuxottica (ESLOY) | France | $132.860B | 0.00 |
| Medtronic (MDT) | Ireland | $108.824B | 15.89 |
| Lonza Group Ag (LZAGY) | Switzerland | $52.624B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.259B | 27.44 |
| ResMed (RMD) | United States | $35.183B | 26.43 |
| GE HealthCare Technologies (GEHC) | United States | $32.295B | 15.33 |
| Terumo (TRUMY) | Japan | $29.019B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $24.053B | 17.17 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.255B | 12.80 |
| Insulet (PODD) | United States | $18.084B | 77.18 |
| Baxter (BAX) | United States | $15.752B | 11.77 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.535B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $7.970B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $7.447B | 18.31 |
| Bio-Rad Laboratories (BIO) | United States | $6.620B | 22.38 |
| Prestige Consumer Healthcare (PBH) | United States | $4.171B | 19.90 |
| Perrigo (PRGO) | Ireland | $3.497B | 10.01 |
| ICU Medical (ICUI) | United States | $3.486B | 29.69 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.208B | 15.10 |
| Envista Holdings (NVST) | United States | $2.880B | 23.93 |
| GN Store Nord (GNNDY) | Denmark | $2.068B | 17.13 |
| QuidelOrtho (QDEL) | United States | $1.964B | 16.45 |
| LeMaitre Vascular (LMAT) | United States | $1.778B | 39.75 |
| AtriCure (ATRC) | United States | $1.486B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.374B | 21.63 |
| Neogen (NEOG) | United States | $1.248B | 15.97 |
| Kestra Medical Technologies (KMTS) | United States | $1.220B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.200B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.184B | 11.40 |
| InMode (INMD) | Israel | $1.013B | 9.28 |
| Phibro Animal Health (PAHC) | United States | $0.789B | 12.10 |
| Evolus (EOLS) | United States | $0.779B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.637B | 0.00 |
| CeriBell (CBLL) | United States | $0.588B | 0.00 |
| Owens & Minor (OMI) | United States | $0.580B | 4.94 |
| Valneva SE (VALN) | France | $0.549B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.542B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.526B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.458B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.442B | 0.00 |
| Omeros (OMER) | United States | $0.418B | 0.00 |
| Surmodics (SRDX) | United States | $0.395B | 0.00 |
| SNDL (SNDL) | Canada | $0.365B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.359B | 15.55 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.296B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.292B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.291B | 26.32 |
| Aurora Cannabis (ACB) | Canada | $0.272B | 48.40 |
| Sanuwave Health (SNWV) | United States | $0.264B | 0.00 |
| ZimVie (ZIMV) | United States | $0.261B | 15.60 |
| Cerus (CERS) | United States | $0.258B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.245B | 0.00 |
| Quanterix (QTRX) | United States | $0.233B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.231B | 0.00 |
| High Tide (HITI) | Canada | $0.194B | 0.00 |
| Biote (BTMD) | United States | $0.190B | 4.35 |
| Utah Medical Products (UTMD) | United States | $0.173B | 13.93 |
| Brainsway (BWAY) | Israel | $0.170B | 53.06 |
| TriSalus Life Sciences (TLSI) | United States | $0.165B | 0.00 |
| Organigram Global (OGI) | Canada | $0.154B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.148B | 18.22 |
| Jin Medical (ZJYL) | China | $0.119B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.116B | 0.00 |
| MacroGenics (MGNX) | United States | $0.110B | 0.00 |
| Exagen (XGN) | United States | $0.108B | 0.00 |
| Agape ATP (ATPC) | $0.099B | 0.00 | |
| Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.094B | 0.00 |
| Fonar (FONR) | United States | $0.076B | 10.70 |
| Jushi Holdings (JUSHF) | United States | $0.076B | 0.00 |
| Veru (VERU) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.073B | 0.00 |
| Zynex (ZYXI) | United States | $0.070B | 0.00 |
| United Health Products (UEEC) | United States | $0.064B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.059B | 0.00 |
| ImmuCell (ICCC) | United States | $0.048B | 0.00 |
| Apyx Medical (APYX) | United States | $0.047B | 0.00 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.042B | 61.50 |
| United-Guardian (UG) | United States | $0.037B | 11.28 |
| Safety Shot (SHOT) | United States | $0.036B | 0.00 |
| Nephros (NEPH) | United States | $0.020B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |